ZNTL
Zentalis Pharmaceuticals Llc
NASDAQ: ZNTL · HEALTHCARE · BIOTECHNOLOGY
$4.01
+1.26% today
Updated 2026-04-30
Market cap
$287.27M
P/E ratio
—
P/S ratio
7.13x
EPS (TTM)
$-1.91
Dividend yield
—
52W range
$1 – $7
Volume
2.2M
Zentalis Pharmaceuticals Llc (ZNTL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $41.00M | $88.23M | $365.56M | $472.02M | $553.46M | $562.03M | $430.34M |
| Cash & equivalents | $25.15M | $67.25M | $54.95M | $59.96M | $43.07M | $28.04M | $33.90M |
| Current assets | $26.68M | $68.89M | $345.10M | $350.77M | $451.93M | $496.72M | $386.07M |
| Total liabilities | $8.69M | $19.81M | $32.18M | $107.54M | $119.43M | $124.64M | $93.15M |
| Current liabilities | $6.21M | $14.90M | $28.60M | $43.94M | $56.65M | $69.37M | $52.73M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $24.77M | $61.60M | $308.58M | $363.95M | $433.80M | $437.28M | $337.19M |
| Retained earnings | $-37.33M | $-82.99M | $-200.83M | $-359.56M | $-596.37M | $-888.56M | $-1.05B |
| Accounts receivable | $917000.00 | $140000.00 | $417000.00 | $2.63M | $7.04M | — | $5.00M |
| Inventory | — | — | — | $-4.44M | $-7.04M | — | — |
| Goodwill | $3.74M | $3.74M | $3.74M | $3.74M | $3.74M | $3.74M | $0.00 |